Search - Industry Global News24

Beginning on June 1, Germany will accept COVAXIN from Bharat Biotech for use in travel

The WHO-listed COVID vaccination COVAXIN from Bharat Biotech has been approved by the German government for use beginning on June 1 in travel to India, according to Walter J Lindner, the German ambassador to India. In November of last year, the World Health Organization (WHO) added COVAXIN to its...

BHARAT BIOTECH TO SELL COVAXIN IN CANADA WITH THE HELP OF OCUGEN

Highlights

• The two companies have already signed an agreement to sell Covaxin in the United States

Indian biotechnology company Bharat Biotech that had developed Covid-19 vaccine Covaxin is now planning to sell it in the country of Canada with Bharat Biotech with the he...

OCUGEN, BHARAT BIOTECH'S AMERICAN PARTNER SUBMITS MASTER FILE ON COVAXIN TO THE US FDA

Highlights

• Ocugen has submitted a "Master File" to the US Food and Drug Administration before seeking an emergency use authorisation (EUA) in the United States

• The Bharat Biotech told the government of India that it has already submitted 90% of document...

BHARAT BIOTECH FILES FOR EMERGENCY USE LISTING FOR COVAXIN

Highlights

• Bharat Biotech told Indian government that the remaining documents are most likely to be submitted by June

• The vaccine developed by the Hyderabad-based company has already received regulatory approval from 11 countries

According to the source...

BHARAT BIOTECH AND CSIR COLLABORATING TO MAKE RAW MATERIAL FOR VACCINES

HIGHLIGHTS

India is importing adjuvants and other chemicals for vaccine manufacturing.
Preservatives for vaccines have been imported from Germany.
Some raw material has also been imported from the USA.

Hyderabad-based Bhar...

OCUGEN SEEKS TO SELL 100 MN DOSES OF COVAXIN IN THE US THIS YEAR

Highlights

• The company is seeking to sell 100 million doses of COVID-19 vaccine developed by India’s Bharat Biotech, COVAXIN in the United States this year

• In an interim analysis of late-stage trial data on nearly 26,000 people in India, this COVID-19 vacci...

INDIA REPORTS 60,975 NEW COVID-19 CASES IN LAST 24 HRS, TALLY AT 3,167,323

• Current Total Cases: 3,167,323

• Total Deaths : 58,390

• Cumulative recoveries : 2,404,585

• Active cases: 704,348

• Top five states that has the maximum number of cases :

Maharashtra: Cases 693,398, number of deat...

INDIA HAS BEST COVID-19 RECOVERY RATE IN THE WORLD SAYS UNION HEALTH MINISTER DR HARSH VARDHAN

According to the statement given by the Union Health Minister Dr Harsh Vardhan on Saturday, India has the best COVID-19 recovery rate in the world as 75 percent of the patients in the country have successfully recovered.
The Union Health Minister said as far as the coronavirus numbers are ...

INDIA’S COVID-19 TALLY SURPASSES 25 LAKH-MARK, DEATH TOLL AT 49,036

• Current Total Cases: 2,526,192

• Total Deaths : 48,036

• Cumulative recoveries : 1,808,936

• Active cases: 668,220

• Top five states that has the maximum number of cases :

Maharashtra: Cases 572,734, number of deat...

COVID-19 VACCINE: BHARAT BIOTECH'S COVAXIN SAFE, PHASE II TRIALS TO START IN SEPTEMBER

Highlights

• Total 375 volunteers across 12 sites in India have been given two shots of this COVID-19 vaccine

• As per the reports, no adverse effects were observed at any of the site and the phase 2 trails will start in the month of September

• COVAXI...

INDIA REPORT 64,553 NEW COVID-19 CASES IN LAST 24 HRS, TALLY AT 2,461,190

• Current Total Cases: 2,461,190

• Total Deaths : 48,040

• Cumulative recoveries : 1,751,555

• Active cases: 661,595

• Top five states that has the maximum number of cases :

Maharashtra: Cases 560,126, number of deat...

INDIA AT THIRD STAGE OF PANDEMIC REPORTS 39,000 INFECTED CASES IN THE LAST HOURS

Highlights:

India expands its testing network, tests more samples
Cases surge as the country surpasses the 3 lakh mark.

India is rapidly going towards a huge surge in its third stage of the pandemic as it reports 39,000 newly infected cas...

FURTHER SIX MONTHS FOR SAFE COVID-19 VACCINE SAYS SERUM INSTITUTE OF INDIA

Serum Institute of India (SII), Indian vaccine developer from the city of Pune has stated that it will take at least six months before we see arrival of COVID-19 vaccine that will be safe to use for general public. The need for the vaccine seems extremely urgent as the number of COVID-19 cases in...